A retrospective observational study on the effects of switching from conventional insulin pump to sensor-augmented pump (SAP) therapy

Research output: Contribution to journalArticle

Abstract

The purpose of this retrospective observational study is to analyze the clinical course of sensor augmented pump (SAP) therapy after switching from insulin pump therapy and to evaluate the predictors of the therapeutic effects of SAP therapy. Twenty-two type 1 diabetes patients who received SAP therapy for more than one year after switching from insulin pump therapy were enrolled. HbAlc levels were unchanged at 6 months and significantly improved at 12 months. The HbAlc levels at 6 months were decreased in 14 patients and unchanged or increased in the other 8 patients. In the latter group with unchanged or increased HbAlc levels at 6 months, the mean HbAlc level at the induction of SAP therapy was significantly lower and the percentage of patients with SMBG <70 mg/dL before SAP therapy was higher in comparison to the former group. A multiple regression analysis showed a significant negative correlation between the change in % TBD (6M) and the change in the HbAlc level (6M). Conclusively, in patients with frequent hypoglycemia, we should evaluate the therapeutic effects based on various parameters, such as average sensor glucose levels and AUC <70 mg/dL, since it is possible that the HbAlc level may transiently increase after the induction of SAP therapy in such cases.

Original languageEnglish
Pages (from-to)315-321
Number of pages7
JournalJournal of the Japan Diabetes Society
Volume62
Issue number5
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Observational Studies
Retrospective Studies
Insulin
Therapeutic Uses
Therapeutics
Type 1 Diabetes Mellitus
Hypoglycemia
Area Under Curve
Regression Analysis
Glucose

Keywords

  • Sensor augmented pump (SAP)

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{5d1cb931c5ad4e649baf27ca18faa251,
title = "A retrospective observational study on the effects of switching from conventional insulin pump to sensor-augmented pump (SAP) therapy",
abstract = "The purpose of this retrospective observational study is to analyze the clinical course of sensor augmented pump (SAP) therapy after switching from insulin pump therapy and to evaluate the predictors of the therapeutic effects of SAP therapy. Twenty-two type 1 diabetes patients who received SAP therapy for more than one year after switching from insulin pump therapy were enrolled. HbAlc levels were unchanged at 6 months and significantly improved at 12 months. The HbAlc levels at 6 months were decreased in 14 patients and unchanged or increased in the other 8 patients. In the latter group with unchanged or increased HbAlc levels at 6 months, the mean HbAlc level at the induction of SAP therapy was significantly lower and the percentage of patients with SMBG <70 mg/dL before SAP therapy was higher in comparison to the former group. A multiple regression analysis showed a significant negative correlation between the change in {\%} TBD (6M) and the change in the HbAlc level (6M). Conclusively, in patients with frequent hypoglycemia, we should evaluate the therapeutic effects based on various parameters, such as average sensor glucose levels and AUC <70 mg/dL, since it is possible that the HbAlc level may transiently increase after the induction of SAP therapy in such cases.",
keywords = "Sensor augmented pump (SAP)",
author = "Satoshi Yamaguchi and Atsuhito Tone and Sanae Teshigawara and Mayu Watanabe and Akihiro Katayama and Satoshi Miyamoto and Jun Eguchi and Atsuko Nakatsuka and Chigusa Higuchi and Daisuke Ogawa and Kenichi Shikata and Jun Wada",
year = "2019",
month = "1",
day = "1",
doi = "10.11213/tonyobyo.62.315",
language = "English",
volume = "62",
pages = "315--321",
journal = "Journal of the Japan Diabetes Society",
issn = "0021-437X",
publisher = "Japan Diabetes Society",
number = "5",

}

TY - JOUR

T1 - A retrospective observational study on the effects of switching from conventional insulin pump to sensor-augmented pump (SAP) therapy

AU - Yamaguchi, Satoshi

AU - Tone, Atsuhito

AU - Teshigawara, Sanae

AU - Watanabe, Mayu

AU - Katayama, Akihiro

AU - Miyamoto, Satoshi

AU - Eguchi, Jun

AU - Nakatsuka, Atsuko

AU - Higuchi, Chigusa

AU - Ogawa, Daisuke

AU - Shikata, Kenichi

AU - Wada, Jun

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The purpose of this retrospective observational study is to analyze the clinical course of sensor augmented pump (SAP) therapy after switching from insulin pump therapy and to evaluate the predictors of the therapeutic effects of SAP therapy. Twenty-two type 1 diabetes patients who received SAP therapy for more than one year after switching from insulin pump therapy were enrolled. HbAlc levels were unchanged at 6 months and significantly improved at 12 months. The HbAlc levels at 6 months were decreased in 14 patients and unchanged or increased in the other 8 patients. In the latter group with unchanged or increased HbAlc levels at 6 months, the mean HbAlc level at the induction of SAP therapy was significantly lower and the percentage of patients with SMBG <70 mg/dL before SAP therapy was higher in comparison to the former group. A multiple regression analysis showed a significant negative correlation between the change in % TBD (6M) and the change in the HbAlc level (6M). Conclusively, in patients with frequent hypoglycemia, we should evaluate the therapeutic effects based on various parameters, such as average sensor glucose levels and AUC <70 mg/dL, since it is possible that the HbAlc level may transiently increase after the induction of SAP therapy in such cases.

AB - The purpose of this retrospective observational study is to analyze the clinical course of sensor augmented pump (SAP) therapy after switching from insulin pump therapy and to evaluate the predictors of the therapeutic effects of SAP therapy. Twenty-two type 1 diabetes patients who received SAP therapy for more than one year after switching from insulin pump therapy were enrolled. HbAlc levels were unchanged at 6 months and significantly improved at 12 months. The HbAlc levels at 6 months were decreased in 14 patients and unchanged or increased in the other 8 patients. In the latter group with unchanged or increased HbAlc levels at 6 months, the mean HbAlc level at the induction of SAP therapy was significantly lower and the percentage of patients with SMBG <70 mg/dL before SAP therapy was higher in comparison to the former group. A multiple regression analysis showed a significant negative correlation between the change in % TBD (6M) and the change in the HbAlc level (6M). Conclusively, in patients with frequent hypoglycemia, we should evaluate the therapeutic effects based on various parameters, such as average sensor glucose levels and AUC <70 mg/dL, since it is possible that the HbAlc level may transiently increase after the induction of SAP therapy in such cases.

KW - Sensor augmented pump (SAP)

UR - http://www.scopus.com/inward/record.url?scp=85067173017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067173017&partnerID=8YFLogxK

U2 - 10.11213/tonyobyo.62.315

DO - 10.11213/tonyobyo.62.315

M3 - Article

VL - 62

SP - 315

EP - 321

JO - Journal of the Japan Diabetes Society

JF - Journal of the Japan Diabetes Society

SN - 0021-437X

IS - 5

ER -